144 related articles for article (PubMed ID: 27086500)
1. Dihydroorotate dehydrogenase depletion hampers mitochondrial function and osteogenic differentiation in osteoblasts.
Fang J; Yamaza H; Uchiumi T; Hoshino Y; Masuda K; Hirofuji Y; Wagener FA; Kang D; Nonaka K
Eur J Oral Sci; 2016 Jun; 124(3):241-5. PubMed ID: 27086500
[TBL] [Abstract][Full Text] [Related]
2. Protein instability and functional defects caused by mutations of dihydro-orotate dehydrogenase in Miller syndrome patients.
Fang J; Uchiumi T; Yagi M; Matsumoto S; Amamoto R; Saito T; Takazaki S; Kanki T; Yamaza H; Nonaka K; Kang D
Biosci Rep; 2012 Dec; 32(6):631-9. PubMed ID: 22967083
[TBL] [Abstract][Full Text] [Related]
3. Miller (Genee-Wiedemann) syndrome represents a clinically and biochemically distinct subgroup of postaxial acrofacial dysostosis associated with partial deficiency of DHODH.
Rainger J; Bengani H; Campbell L; Anderson E; Sokhi K; Lam W; Riess A; Ansari M; Smithson S; Lees M; Mercer C; McKenzie K; Lengfeld T; Gener Querol B; Branney P; McKay S; Morrison H; Medina B; Robertson M; Kohlhase J; Gordon C; Kirk J; Wieczorek D; Fitzpatrick DR
Hum Mol Genet; 2012 Sep; 21(18):3969-83. PubMed ID: 22692683
[TBL] [Abstract][Full Text] [Related]
4. Dihydro-orotate dehydrogenase is physically associated with the respiratory complex and its loss leads to mitochondrial dysfunction.
Fang J; Uchiumi T; Yagi M; Matsumoto S; Amamoto R; Takazaki S; Yamaza H; Nonaka K; Kang D
Biosci Rep; 2013 Feb; 33(2):e00021. PubMed ID: 23216091
[TBL] [Abstract][Full Text] [Related]
5. Elevated plasma dihydroorotate in Miller syndrome: Biochemical, diagnostic and clinical implications, and treatment with uridine.
Duley JA; Henman MG; Carpenter KH; Bamshad MJ; Marshall GA; Ooi CY; Wilcken B; Pinner JR
Mol Genet Metab; 2016 Sep; 119(1-2):83-90. PubMed ID: 27370710
[TBL] [Abstract][Full Text] [Related]
6. Miller syndrome with novel dihydroorotate dehydrogenase gene mutations.
Kinoshita F; Kondoh T; Komori K; Matsui T; Harada N; Yanai A; Fukuda M; Morifuji K; Matsumoto T
Pediatr Int; 2011 Aug; 53(4):587-91. PubMed ID: 21851494
[No Abstract] [Full Text] [Related]
7. Dihydroorotate dehydrogenase (DHODH) inhibitors affect ATP depletion, endogenous ROS and mediate S-phase arrest in breast cancer cells.
Mohamad Fairus AK; Choudhary B; Hosahalli S; Kavitha N; Shatrah O
Biochimie; 2017 Apr; 135():154-163. PubMed ID: 28196676
[TBL] [Abstract][Full Text] [Related]
8. Dihydroorotate Dehydrogenase Inhibitors Promote Cell Cycle Arrest and Disrupt Mitochondria Bioenergetics in Ramos Cells.
Kadir MFA; Othman S; Nellore K
Curr Pharm Biotechnol; 2020; 21(15):1654-1665. PubMed ID: 32525770
[TBL] [Abstract][Full Text] [Related]
9. Protein production, kinetic and biophysical characterization of three human dihydroorotate dehydrogenase mutants associated with Miller syndrome.
Orozco Rodriguez JM; Krupinska E; Wacklin-Knecht H; Knecht W
Nucleosides Nucleotides Nucleic Acids; 2022; 41(12):1318-1336. PubMed ID: 35094635
[TBL] [Abstract][Full Text] [Related]
10. The dual-effects of LaCl₃ on the proliferation, osteogenic differentiation, and mineralization of MC3T3-E1 cells.
Liu D; Zhang J; Wang G; Liu X; Wang S; Yang M
Biol Trace Elem Res; 2012 Dec; 150(1-3):433-40. PubMed ID: 22886987
[TBL] [Abstract][Full Text] [Related]
11. Differential circRNA expression profiles during the BMP2-induced osteogenic differentiation of MC3T3-E1 cells.
Qian DY; Yan GB; Bai B; Chen Y; Zhang SJ; Yao YC; Xia H
Biomed Pharmacother; 2017 Jun; 90():492-499. PubMed ID: 28395271
[TBL] [Abstract][Full Text] [Related]
12. miR-23b targets Smad 3 and ameliorates the LPS-inhibited osteogenic differentiation in preosteoblast MC3T3-E1 cells.
Liu H; Hao W; Wang X; Su H
J Toxicol Sci; 2016 Apr; 41(2):185-93. PubMed ID: 26961602
[TBL] [Abstract][Full Text] [Related]
13. Revisiting the role of dihydroorotate dehydrogenase as a therapeutic target for cancer.
Madak JT; Bankhead A; Cuthbertson CR; Showalter HD; Neamati N
Pharmacol Ther; 2019 Mar; 195():111-131. PubMed ID: 30347213
[TBL] [Abstract][Full Text] [Related]
14. Protein-lipid interactions of human dihydroorotate dehydrogenase and three mutants associated with Miller syndrome.
Orozco Rodriguez JM; Wacklin-Knecht H; Knecht W
Nucleosides Nucleotides Nucleic Acids; 2022; 41(12):1337-1358. PubMed ID: 35184687
[TBL] [Abstract][Full Text] [Related]
15. Uncarboxylated osteocalcin inhibits high glucose-induced ROS production and stimulates osteoblastic differentiation by preventing the activation of PI3K/Akt in MC3T3-E1 cells.
Liu J; Yang J
Int J Mol Med; 2016 Jan; 37(1):173-81. PubMed ID: 26719856
[TBL] [Abstract][Full Text] [Related]
16. Negative regulation of osteoblastogenesis through downregulation of runt-related transcription factor-2 in osteoblastic MC3T3-E1 cells with stable overexpression of the cystine/glutamate antiporter xCT subunit.
Uno K; Takarada T; Takarada-Iemata M; Nakamura Y; Fujita H; Hinoi E; Yoneda Y
J Cell Physiol; 2011 Nov; 226(11):2953-64. PubMed ID: 21302293
[TBL] [Abstract][Full Text] [Related]
17. Extra phenotypic features in a girl with Miller syndrome.
Al Kaissi A; Roetzer KM; Ulz P; Heitzer E; Klaushofer K; Grill F
Clin Dysmorphol; 2011 Apr; 20(2):66-72. PubMed ID: 21346561
[TBL] [Abstract][Full Text] [Related]
18. Teriflunomide treatment for multiple sclerosis modulates T cell mitochondrial respiration with affinity-dependent effects.
Klotz L; Eschborn M; Lindner M; Liebmann M; Herold M; Janoschka C; Torres Garrido B; Schulte-Mecklenbeck A; Gross CC; Breuer J; Hundehege P; Posevitz V; Pignolet B; Nebel G; Glander S; Freise N; Austermann J; Wirth T; Campbell GR; Schneider-Hohendorf T; Eveslage M; Brassat D; Schwab N; Loser K; Roth J; Busch KB; Stoll M; Mahad DJ; Meuth SG; Turner T; Bar-Or A; Wiendl H
Sci Transl Med; 2019 May; 11(490):. PubMed ID: 31043571
[TBL] [Abstract][Full Text] [Related]
19. Protein S-glutathionylation and sex dimorphic effects on hydrogen peroxide production by dihydroorotate dehydrogenase in liver mitochondria.
Koufos O; Mailloux RJ
Free Radic Biol Med; 2023 Jan; 194():123-130. PubMed ID: 36462627
[TBL] [Abstract][Full Text] [Related]
20. Fidgetin-like 1 gene inhibited by basic fibroblast growth factor regulates the proliferation and differentiation of osteoblasts.
Park SJ; Kim SJ; Rhee Y; Byun JH; Kim SH; Kim MH; Lee EJ; Lim SK
J Bone Miner Res; 2007 Jun; 22(6):889-96. PubMed ID: 17352653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
